Table 2.

Summary of follow-up in 320 untreated hepatocellular carcinoma patients (%)

Outcome	Patients (n = 320)
Death	292 (91)
Overall survival
Median (95%CI) (mo)	6.8 (5.8-7.7)
1-yr survival rate	32
2-yr survival rate	13
BCLC A (early stage) survival
Median (95%CI) (mo)	33 (20-46)
1-yr survival rate	100
2-yr survival rate	57
3-yr survival rate	41
BCLC B (intermediate stage) survival
Median (95%CI) (mo)	17.4 (14.8-20)
1-yr survival rate	79
2-yr survival rate	22
3-yr survival rate	5
BCLC C (advanced stage) survival
Median (95%CI) (mo)	6.9 (6.3-7.3)
1-yr survival rate	12
BCLC D (end-stage) survival
Median (95%CI) (mo)	1.8 (1.2-2.4)
1-yr survival rate	0

BCLC: Barcelona Clinic Liver Cancer classification.